Search & Analyze

Remus Pharmaceuticals Ltd.

TradingTrading

www.remuspharma.comBSE: N/ANSE: REMUS

₹866.35NSE

₹866.35

₹1.02K Cr

27.60

2.91

18.58%

₹0.00

Customise metrics bar

Price Performance

Peer Comparison

Name
ADANI ENTER ADANIENT	2,924.10	53.17	3,95,842.03	0.04	-1,461.54	-249.67%	32,923.98	49.92%	13.30
AEGISLOG AEGISLOG	1,381.20	38.75	48,480.12	0.63	544.84	210.70%	2,356.86	37.07%	19.76
CPPLUS CPPLUS	3,555.00	87.91	42,055.80	0.05	142.20	332.51%	1,402.42	89.51%	29.48
PREMIERENE PREMIERENE	899.00	24.51	40,810.24	0.11	471.92	53.32%	2,462.59	35.25%	33.72
REDINGTON REDINGTON	387.35	17.84	30,282.03	1.55	453.49	94.65%	34,922.47	34.57%	18.96
HONASA HONASA	471.35	61.40	15,367.15	0.64	90.45	118.87%	755.95	27.00%	20.87
LLOYDSENT LLOYDSENT	66.70	91.03	10,182.10	0.22	109.98	-55.77%	563.03	70.15%	12.84
Remus Pharmaceuticals Ltd. REMUS	866.35	27.60	1,020.91	0.12					21.89

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2023-24 (Mar)	FY 2024-25 (Mar)
No of Months	12.00	12.00
INCOME :
	212.94	620.36
	212.94	620.36
EXPENDITURE :
Increase/Decrease in Stock	-0.77	-8.44
Raw Material Consumed	164.14	541.31
Power & Fuel Cost	0.01	0.06
Employee Cost	7.32	13.11
Other Manufacturing Expenses	2.30	7.20
General and Administration Expenses	9.18	19.04
Selling and Distribution Expenses	1.60	1.44
Miscellaneous Expenses	0.20	0.95
	183.98	574.67
Operating Profit (Excl OI)	28.96	45.69
	2.83	4.98
	31.79	50.67
Interest	0.50	1.46
PBDT	31.29	49.21
	1.12	1.87
Profit Before Taxation & Exceptional Items	30.17	47.34
	30.17	47.34
Provision for Tax	5.89	8.92
	24.28	38.42
Minority Interest	-3.75	-9.35
Consolidated Net Profit	20.53	29.07
Adjustments to PAT	-0.01
Profit Balance B/F	13.78	33.71
Appropriations	34.30	62.78
Equity Dividend %	60.00%	15.00%
	139.66	49.35
Adjusted EPS	17.46	24.68

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2023-24 (Mar)	FY 2024-25 (Mar)
	1.47	5.89
Total Reserves	156.22	249.97
Reserve excluding Revaluation Reserve	156.22	249.97
	157.69	255.86
Minority Interest	17.52	26.69
Secured Loans	1.23	1.78
Unsecured Loans	1.77	1.55
Deferred Tax Assets / Liabilities	11.16	22.90
Other Long Term Liabilities	2.17	1.66
Long Term Provisions	0.46	0.67
Total Non-Current Liabilities	16.79	28.56
Trade Payables	93.71	71.29
Other Current Liabilities	37.20	29.54
Short Term Borrowings	8.34	17.12
Short Term Provisions	1.86	3.58
Total Current Liabilities	141.11	121.53
Total Liabilities	333.11	432.64
Gross Block	15.86	19.25
Less: Accumulated Depreciation	2.07	3.49
Net Block	13.79	15.76
Capital Work in Progress	0.01
Non Current Investments	104.38	186.12
Long Term Investment	104.38	186.12
Long Term Loans & Advances	0.59	0.12
Other Non Current Assets	2.01	9.21
Total Non-Current Assets	120.78	211.27
Currents Investments	0.14
Inventories	43.11	51.56
Sundry Debtors	115.29	108.03
Cash and Bank	13.85	8.14
Other Current Assets	0.04	0.32
Short Term Loans and Advances	39.90	53.32
Total Current Assets	212.33	221.37
Net Current Assets (Including Current Investments)	71.22	99.84
Total Assets	333.11	432.64
Contingent Liabilities	75.35
Total Debt	11.55	20.81
	1,072.72	434.40
Adjusted Book Value	134.09	217.20

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2023-24 (Mar)	FY 2024-25 (Mar)
No of Months	12.00	12.00
	30.17	47.34
Adjustment	-0.54	0.23
Changes In working Capital	-22.47	-33.12
Cash Flow after changes in Working Capital	7.16	14.45
Cash Flow from Operating Activities	1.35	6.98
Cash Flow from Investing Activities	-30.11	-10.55
Cash Flow from Financing Activitie	27.67	6.07
Net Cash Inflow / Outflow	-1.09	2.50
Opening Cash & Cash Equivalents	1.01	4.73
Cash & Cash Equivalent on Amalgamation / Take over / Merger	4.80
Closing Cash & Cash Equivalent	4.72	7.23

Ratios

Valuation

27.60

2.91

16.30

1.20

31.39

297.86

Profitability

18.58

21.89

10.03

7.37

6.19

Leverage & Liquidity

0.08

1.82

33.42

Returns

0.12

1.62

Shareholding Pattern

Numbers in percentages

Particulars	Sep '23	Mar '24	Sep '24	Mar '25	Sep '25	Mar '26
	69.61	70.60	70.84	70.85	70.91	70.95
	3.09	3.92	3.93	5.54	5.79	6.11
	27.30	25.49	25.22	23.60	23.31	22.94
	30.39	29.40	29.16	29.15	29.09	29.05
No. of Shareholders	856	1,124	1,753	1,878	2,032	2,009

Corporate Actions

Showing: All

Date	Type	Details	Record Date
2026-09-07	AGM	Remus Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026
2026-05-20	Ex Dividend		2026-09-22
2026-05-13	Board Meeting	Financial Results/Dividend/Other business matters

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

TradingTrading

Remus Pharmaceuticals Ltd. operates in the Trading sector under the Trading industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Deval Bakulkumar Patel

Company Secretary & Compliance Officer

—

Arpit Deepakkumar Shah

Managing Director

—

Swapnil Jatinbhai Shah

Chairman

—

Roma Vinodbhai Shah

Whole Time Director

—

Anar Swapnil Shah

Non Independent & Non Executive Director

—

Vishrut Chandramauli Pathak

Non Executive Independent Director

—

Balwant Purohit

Non Executive Independent Director

—

Sanjana Sanjeev Shah

Non Executive Independent Director

—

REMUS Latest News

News

No news found for Remus Pharmaceuticals Ltd..

REMUS

₹866.35

+0%